Literature DB >> 8482921

Functional alterations of human neutrophils by medium-chain triglyceride emulsions: evaluation of phagocytosis, bacterial killing, and oxidative activity.

R Bellinati-Pires1, D L Waitzberg, M M Salgado, M M Carneiro-Sampaio.   

Abstract

Medium-chain triglyceride (MCT) and long-chain triglyceride (LCT) emulsions currently used in nutritional therapy were evaluated for their in vitro effect on neutrophil oxidative metabolism, phagocytosis, and bacterial killing activities. Neutrophils from healthy adult male volunteers were assessed after blood incubation with commercially available fat emulsions containing LCT, MCT, or a mixture of 50% MCT and 50% LCT at a final triglyceride concentration of 20 mg/ml. It was observed that MCT-containing emulsions stimulated nitroblue tetrazolium (NBT) dye reduction by neutrophils as determined by a cytochemical NBT test performed directly on whole blood. This effect was dose dependent. However, after lipid removal by cell washing, the MCT-treated neutrophils showed decreased production of hydrogen peroxide (H2O2) and NBT reduction in response to bacterial lipopolysaccharide or phorbol myristate acetate stimuli as well as impaired phagocytosis and killing of Staphylococcus aureus. In contrast, the LCT emulsion did not alter any of the neutrophil functions evaluated. The present data suggest that MCTs elicit the oxidative metabolism of neutrophils, probably by phagocytosis of fat particles and, depending on the lipid concentration, this effect may not be reversible, leading to impairment of the cellular response to subsequent membrane stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482921     DOI: 10.1002/jlb.53.4.404

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man.

Authors:  D S Halvorsen; J B Hansen; S Grimsgaard; K H Bønaa; P Kierulf; A Nordøy
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

2.  Olive Oil-Based Lipid Emulsions Do Not Influence Platelet Receptor Expression in Comparison to Medium and Long Chain Triglycerides In vitro.

Authors:  Carsten Stoetzer; Katja Nickel; Annette Weißig; Marieke Großheim; Dirk Scheinichen; Thorben Doll; Björn Jüttner
Journal:  Lipids       Date:  2016-08-12       Impact factor: 1.880

3.  Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.

Authors:  Geert J Wanten; Mihai G Netea; Ton H Naber; Jo H Curfs; Liesbeth E Jacobs; Trees J Verver-Jansen; Bart-Jan Kullberg
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Lipid emulsions differentially affect LPS-induced acute monocytes inflammation: in vitro effects on membrane remodeling and cell viability.

Authors:  Julie Boisramé-Helms; Xavier Delabranche; Andrey Klymchenko; Jocelyne Drai; Emilie Blond; Fatiha Zobairi; Yves Mely; Michel Hasselmann; Florence Toti; Ferhat Meziani
Journal:  Lipids       Date:  2014-07-20       Impact factor: 1.880

5.  Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis.

Authors:  Uju L Madu; Adepemi O Ogundeji; Bonang M Mochochoko; Carolina H Pohl; Jacobus Albertyn; Chantel W Swart; J William Allwood; Andrew D Southam; Warwick B Dunn; Robin C May; Olihile M Sebolai
Journal:  Front Microbiol       Date:  2015-12-09       Impact factor: 5.640

6.  Docosahexaenoate-enriched fish oil and medium chain triglycerides shape the feline plasma lipidome and synergistically decrease circulating gut microbiome-derived putrefactive postbiotics.

Authors:  Matthew I Jackson; Dennis E Jewell
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

7.  Unsaturated long-chain fatty acids induce the respiratory burst of human neutrophils and monocytes in whole blood.

Authors:  Björn Jüttner; Janina Kröplin; Sina M Coldewey; Lars Witt; Wilhelm A Osthaus; Christian Weilbach; Dirk Scheinichen
Journal:  Nutr Metab (Lond)       Date:  2008-07-14       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.